Disclosure Panels Details Page
Hodgkin Lymphoma Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Ranjana Advani MD | ADC Therapeutics BeiGene Bristol-Myers Squibb Company Conjupro Cyteir Daiichi- Sankyo Co. Epizyme Genentech/Roche Gilead Sciences, Inc. Merck & Co., Inc. MorphoSys AG Regeneron Pharmaceuticals, Inc. Seattle Genetics, Inc. |
ADC Therapeutics BeiGene Genentech/Roche |
None | None | 04/06/2023 |
| Richard Ambinder PhD,MD | None | legal | None | None | 02/19/2023 |
| Philippe Armand PhD,MD | Adaptive ADC Therapeutics AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Genentech, Inc. IGM Kite Pharma Merck & Co., Inc. Tessa |
ATB Bio Bristol-Myers Squibb Company Enterome Foresight Genentech, Inc. GenMab Merck & Co., Inc. Roche Laboratories, Inc. Wickersmith Xencor |
None | None | 04/28/2023 |
| Celeste Bello MSPH,MD | None | Monsanto Corporation Seattle Genetics, Inc. |
None | None | 01/20/2023 |
| Cecil Benitez PhD,MD | None | None | None | None | 03/17/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Weina Chen PhD,MD | None | None | None | None | 12/19/2022 |
| Sheen Cherian MD | None | None | None | None | 04/06/2023 |
| Bouthaina Dabaja MD | None | None | None | None | 02/02/2023 |
| Megan Daly MD | EMD Serono Genentech, Inc. Merck & Co., Inc. |
None | AstraZeneca Pharmaceuticals LP Novocure |
None | 03/06/2023 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 05/22/2023 |
| Mary Dwyer MS | None | None | None | None | 05/11/2023 |
| Jamie Flerlage MS,MD | Seattle Genetics, Inc. Teva Pharmaceutical Industries Ltd |
None | Seattle Genetics, Inc. | None | 04/07/2023 |
| Zachary Frosch MD,MSHP | Roche Laboratories, Inc. | Seattle Genetics, Inc. | None | None | 02/02/2023 |
| Kai Fu PhD,MD | None | None | None | None | 02/02/2023 |
| Leo Gordon MD | Janssen Pharmaceutica Products, LP Zylem Biosciences |
Bristol-Myers Squibb Company Epizyme Janssen Pharmaceutica Products, LP Ono Pharmaceuticals |
None | None | 03/14/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Neil Hansen MD | None | None | None | None | 02/24/2023 |
| Alex Herrera MD | None | AbbVie, Inc. ADC Therapeutics Adicet Bio AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Caribou Genentech, Inc. Genmab Karyopharm Therapeutics Merck & Co., Inc. Pfizer Inc. Regeneron Pharmaceuticals, Inc. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. Tubulis |
None | None | 04/12/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Ephraim Hochberg MD | None | Intervention Insights Leuko |
None | None | 04/06/2023 |
| Richard Hoppe MD | None | Hart Wagner, LLP ., Portland, OR | None | None | 04/11/2023 |
| Iris Isufi MD | None | None | AbbVie, Inc. ADC Therapeutics Caribou bisociences Genmab Incyte Corporation Kite Pharma |
None | 04/15/2023 |
| Patrick Johnston MD,PhD | None | None | None | None | 03/31/2023 |
| Madeline Joyce OCN,RN,BSN | None | None | None | None | 05/23/2023 |
| Christopher Kelsey MD | Galera Therapeutics | Colgate-Palmolive Johnson & Johnson |
None | None | 05/26/2023 |
| Vaishalee Kenkre MD | None | None | None | None | 02/01/2023 |
| Ryan Lynch MD | Bayer HealthCare Cyteir Genentech, Inc. Incyte Corporation Merck & Co., Inc. RAPT Seattle Genetics, Inc. TG Therapeutics |
Cancer Study Group Foresight Diagnostics SeaGen |
None | None | 02/18/2023 |
| Kami Maddocks MD | None | AbbVie, Inc. Acerta Pharma AstraZeneca Pharmaceuticals LP BeiGene Bristol-Myers Squibb Company Celgene Corporation Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Seattle Genetics, Inc. |
None | None | 01/11/2023 |
| Jonathan McConathy PhD,MD | Blue Earth Diagnostics Clovis Oncology Cytosite Fusion Pharmaceuticals ImaginAb Navidea Novartis Pharmaceuticals Corporation |
Blue Earth Diagnostics Eli Lilly and Company General Electric ImaginAb Novartis Pharmaceuticals Corporation |
None | None | 04/13/2023 |
| Sarah Montgomery | None | None | None | None | 03/22/2023 |
| David Morgan MD | None | None | None | None | 11/18/2022 |
| Carolyn Mulroney MD | Amgen Inc. Angiocrine Atara Biotherapeutics CALIBR, Scripps research institute Novartis Pharmaceuticals Corporation |
None | None | None | 03/28/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Sheeja Pullarkat MD | None | None | Blueprint Medicines EUSA Stemline |
None | 03/06/2023 |
| Rachel Rabinovitch MD | None | None | None | None | 03/27/2023 |
| Karen Rosenspire PhD,MD | None | McCollum and Associates | None | None | 02/14/2023 |
| Dahlia Sano MBChB | None | None | None | None | 02/04/2023 |
| Michael Spinner MD | None | None | None | None | 01/27/2023 |
| Katie Stehman MMS,PA-C | None | None | None | None | 01/18/2023 |
| Randa Tao MD | None | None | None | None | 03/06/2023 |
| Erin Vidic | None | None | None | None | 02/13/2023 |
| Jane Winter MD | Astellas Pharma US, Inc. Cellectis Daiichi- Sankyo Co. Epizyme Forty Seven, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
CVS Caremark -Spouse ImmunoGen, Inc. Jazz Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation Rigel (Spouse) Servier- Spouse Takeda Pharmaceuticals North America, Inc. |
None | None | 01/22/2023 |
| Joachim Yahalom MD | None | None | Convergent | None | 04/12/2023 |
| Joanna Yang MD,MPH | Veil Therapeutics | None | None | None | 02/02/2023 |